Real Estate - Services
Compare Stocks
4 / 10Stock Comparison
EXPI vs WELL vs VTR vs COMP
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Healthcare Facilities
Software - Application
EXPI vs WELL vs VTR vs COMP — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Real Estate - Services | REIT - Healthcare Facilities | REIT - Healthcare Facilities | Software - Application |
| Market Cap | $1.01B | $150.14B | $41.26B | $4.08B |
| Revenue (TTM) | $4.77B | $11.63B | $6.13B | $8.31B |
| Net Income (TTM) | $-23M | $1.43B | $260M | $14M |
| Gross Margin | 7.0% | 39.1% | -4.3% | 10.8% |
| Operating Margin | -0.4% | 4.4% | 13.4% | -4.2% |
| Forward P/E | 89.7x | 78.9x | 118.3x | 44.4x |
| Total Debt | $0.00 | $21.38B | $13.22B | $454M |
| Cash & Equiv. | $124M | $5.03B | $741M | $199M |
EXPI vs WELL vs VTR vs COMP — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Apr 21 | May 26 | Return |
|---|---|---|---|
| eXp World Holdings,… (EXPI) | 100 | 18.3 | -81.7% |
| Welltower Inc. (WELL) | 100 | 285.6 | +185.6% |
| Ventas, Inc. (VTR) | 100 | 156.5 | +56.5% |
| Compass, Inc. (COMP) | 100 | 38.2 | -61.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EXPI vs WELL vs VTR vs COMP
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EXPI is the #2 pick in this set and the best alternative if dividends is your priority.
- 3.1% yield, vs WELL's 1.3%, (1 stock pays no dividend)
WELL carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 35.8%, EPS growth -11.5%, 3Y rev CAGR 22.7%
- 230.2% 10Y total return vs EXPI's 6.6%
- Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
- 35.8% FFO/revenue growth vs EXPI's 4.5%
VTR is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 1 yrs, beta 0.01, yield 2.1%
- Beta 0.01, yield 2.1%, current ratio 0.96x
- Beta 0.01 vs COMP's 1.79
COMP is the clearest fit if your priority is value.
- Lower P/E (44.4x vs 118.3x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.8% FFO/revenue growth vs EXPI's 4.5% | |
| Value | Lower P/E (44.4x vs 118.3x) | |
| Quality / Margins | 12.3% margin vs EXPI's -0.5% | |
| Stability / Safety | Beta 0.01 vs COMP's 1.79 | |
| Dividends | 3.1% yield, vs WELL's 1.3%, (1 stock pays no dividend) | |
| Momentum (1Y) | +43.9% vs EXPI's -25.7% | |
| Efficiency (ROA) | 2.3% ROA vs EXPI's -5.1%, ROIC 0.5% vs -15.3% |
EXPI vs WELL vs VTR vs COMP — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
EXPI vs WELL vs VTR vs COMP — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
WELL leads in 2 of 6 categories
VTR leads 1 • EXPI leads 0 • COMP leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — WELL and VTR and COMP each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 2.4x EXPI's $4.8B. WELL is the more profitable business, keeping 12.3% of every revenue dollar as net income compared to EXPI's -0.5%. On growth, COMP holds the edge at +99.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $4.8B | $11.6B | $6.1B | $8.3B |
| EBITDAEarnings before interest/tax | -$12M | $2.8B | $2.3B | -$100M |
| Net IncomeAfter-tax profit | -$23M | $1.4B | $260M | $14M |
| Free Cash FlowCash after capex | $108M | $2.5B | $1.4B | $16M |
| Gross MarginGross profit ÷ Revenue | +7.0% | +39.1% | -4.3% | +10.8% |
| Operating MarginEBIT ÷ Revenue | -0.4% | +4.4% | +13.4% | -4.2% |
| Net MarginNet income ÷ Revenue | -0.5% | +12.3% | +4.2% | +0.2% |
| FCF MarginFCF ÷ Revenue | +2.3% | +21.9% | +22.4% | +0.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +8.5% | +40.3% | +22.0% | +99.4% |
| EPS Growth (YoY)Latest quarter vs prior year | -24.4% | +22.5% | 0.0% | +133.3% |
Valuation Metrics
Evenly matched — EXPI and VTR and COMP each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 154.2x trailing earnings, WELL trades at a 4% valuation discount to VTR's 160.7x P/E. On an enterprise value basis, VTR's 24.4x EV/EBITDA is more attractive than WELL's 66.8x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $1.0B | $150.1B | $41.3B | $4.1B |
| Enterprise ValueMkt cap + debt − cash | $887M | $166.5B | $53.7B | $4.3B |
| Trailing P/EPrice ÷ TTM EPS | -44.86x | 154.17x | 160.70x | -72.60x |
| Forward P/EPrice ÷ next-FY EPS est. | 89.71x | 78.89x | 118.34x | 44.40x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 66.76x | 24.36x | 51.99x |
| Price / SalesMarket cap ÷ Revenue | 0.21x | 14.08x | 7.07x | 0.59x |
| Price / BookPrice ÷ Book value/share | 4.13x | 3.37x | 3.19x | 5.27x |
| Price / FCFMarket cap ÷ FCF | 9.28x | 52.72x | 31.34x | 20.07x |
Profitability & Efficiency
WELL leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
WELL delivers a 3.5% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $-9 for EXPI. WELL carries lower financial leverage with a 0.49x debt-to-equity ratio, signaling a more conservative balance sheet compared to VTR's 1.05x. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs COMP's 4/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -9.4% | +3.5% | +2.1% | +1.1% |
| ROA (TTM)Return on assets | -5.1% | +2.3% | +1.0% | +0.4% |
| ROICReturn on invested capital | -15.3% | +0.5% | +2.5% | -2.5% |
| ROCEReturn on capital employed | -9.6% | +0.6% | +3.2% | -2.9% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 7 | 6 | 4 |
| Debt / EquityFinancial leverage | — | 0.49x | 1.05x | 0.58x |
| Net DebtTotal debt minus cash | -$124M | $16.3B | $12.5B | $255M |
| Cash & Equiv.Liquid assets | $124M | $5.0B | $741M | $199M |
| Total DebtShort + long-term debt | $0 | $21.4B | $13.2B | $454M |
| Interest CoverageEBIT ÷ Interest expense | — | 0.26x | 1.40x | -0.12x |
Total Returns (Dividends Reinvested)
WELL leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $31,264 today (with dividends reinvested), compared to $2,329 for EXPI. Over the past 12 months, WELL leads with a +43.9% total return vs EXPI's -25.7%. The 3-year compound annual growth rate (CAGR) favors COMP at 42.9% vs EXPI's -19.5% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -30.4% | +15.0% | +12.9% | -30.9% |
| 1-Year ReturnPast 12 months | -25.7% | +43.9% | +33.2% | -8.2% |
| 3-Year ReturnCumulative with dividends | -47.9% | +182.2% | +93.0% | +191.6% |
| 5-Year ReturnCumulative with dividends | -76.7% | +212.6% | +80.0% | -57.5% |
| 10-Year ReturnCumulative with dividends | +662.8% | +230.2% | +67.4% | -64.0% |
| CAGR (3Y)Annualised 3-year return | -19.5% | +41.3% | +24.5% | +42.9% |
Risk & Volatility
VTR leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
VTR is the less volatile stock with a 0.01 beta — it tends to amplify market swings less than COMP's 1.79 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VTR currently trades 98.1% from its 52-week high vs EXPI's 51.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.57x | 0.13x | 0.01x | 1.79x |
| 52-Week HighHighest price in past year | $12.23 | $219.59 | $88.50 | $13.96 |
| 52-Week LowLowest price in past year | $5.66 | $142.65 | $61.76 | $5.66 |
| % of 52W HighCurrent price vs 52-week peak | +51.3% | +97.6% | +98.1% | +52.0% |
| RSI (14)Momentum oscillator 0–100 | 47.1 | 62.6 | 62.0 | 38.4 |
| Avg Volume (50D)Average daily shares traded | 1.0M | 2.6M | 3.3M | 14.1M |
Analyst Outlook
Evenly matched — EXPI and WELL each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: EXPI as "Buy", WELL as "Buy", VTR as "Buy", COMP as "Buy". Consensus price targets imply 96.8% upside for COMP (target: $14) vs 4.6% for VTR (target: $91). For income investors, EXPI offers the higher dividend yield at 3.07% vs WELL's 1.29%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $11.00 | $226.50 | $90.80 | $14.29 |
| # AnalystsCovering analysts | 5 | 34 | 32 | 10 |
| Dividend YieldAnnual dividend ÷ price | +3.1% | +1.3% | +2.1% | — |
| Dividend StreakConsecutive years of raises | 0 | 2 | 1 | — |
| Dividend / ShareAnnual DPS | $0.19 | $2.76 | $1.86 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +5.6% | 0.0% | 0.0% | 0.0% |
WELL leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). VTR leads in 1 (Risk & Volatility). 3 tied.
EXPI vs WELL vs VTR vs COMP: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is EXPI or WELL or VTR or COMP a better buy right now?
For growth investors, Welltower Inc.
(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus 4. 5% for eXp World Holdings, Inc. (EXPI). Welltower Inc. (WELL) offers the better valuation at 154. 2x trailing P/E (78. 9x forward), making it the more compelling value choice. Analysts rate eXp World Holdings, Inc. (EXPI) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EXPI or WELL or VTR or COMP?
On trailing P/E, Welltower Inc.
(WELL) is the cheapest at 154. 2x versus Ventas, Inc. at 160. 7x. On forward P/E, Compass, Inc. is actually cheaper at 44. 4x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — EXPI or WELL or VTR or COMP?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +212. 6%, compared to -76. 7% for eXp World Holdings, Inc. (EXPI). Over 10 years, the gap is even starker: EXPI returned +662. 8% versus COMP's -64. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EXPI or WELL or VTR or COMP?
By beta (market sensitivity over 5 years), Ventas, Inc.
(VTR) is the lower-risk stock at 0. 01β versus Compass, Inc. 's 1. 79β — meaning COMP is approximately 18737% more volatile than VTR relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 49% versus 105% for Ventas, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — EXPI or WELL or VTR or COMP?
By revenue growth (latest reported year), Welltower Inc.
(WELL) is pulling ahead at 35. 8% versus 4. 5% for eXp World Holdings, Inc. (EXPI). On earnings-per-share growth, the picture is similar: Ventas, Inc. grew EPS 184. 2% year-over-year, compared to -11. 5% for Welltower Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EXPI or WELL or VTR or COMP?
Welltower Inc.
(WELL) is the more profitable company, earning 8. 8% net margin versus -0. 8% for Compass, Inc. — meaning it keeps 8. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VTR leads at 14. 2% versus -0. 4% for EXPI. At the gross margin level — before operating expenses — WELL leads at 39. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EXPI or WELL or VTR or COMP more undervalued right now?
On forward earnings alone, Compass, Inc.
(COMP) trades at 44. 4x forward P/E versus 118. 3x for Ventas, Inc. — 73. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for COMP: 96. 8% to $14. 29.
08Which pays a better dividend — EXPI or WELL or VTR or COMP?
In this comparison, EXPI (3.
1% yield), VTR (2. 1% yield), WELL (1. 3% yield) pay a dividend. COMP does not pay a meaningful dividend and should not be held primarily for income.
09Is EXPI or WELL or VTR or COMP better for a retirement portfolio?
For long-horizon retirement investors, Ventas, Inc.
(VTR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 01), 2. 1% yield). Compass, Inc. (COMP) carries a higher beta of 1. 79 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (VTR: +67. 4%, COMP: -64. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EXPI and WELL and VTR and COMP?
These companies operate in different sectors (EXPI (Real Estate) and WELL (Real Estate) and VTR (Real Estate) and COMP (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: EXPI is a small-cap income-oriented stock; WELL is a mid-cap high-growth stock; VTR is a mid-cap high-growth stock; COMP is a small-cap high-growth stock. EXPI, WELL, VTR pay a dividend while COMP does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.